Karyogram in neonatology: Necessity or past?

Svjetlana Grubeša Raguž , Marjana Jerković Raguž , Marija Novaković Bošnjak , Darinka Šumanović-Glamuzina , Tomica Božić

Global Medical Genetics ›› 2025, Vol. 12 ›› Issue (03) : 100053

PDF (855KB)
Global Medical Genetics ›› 2025, Vol. 12 ›› Issue (03) :100053 DOI: 10.1016/j.gmg.2025.100053
Research article
research-article
Karyogram in neonatology: Necessity or past?
Author information +
History +
PDF (855KB)

Abstract

Objective This research was conducted at the Clinic for Children's Diseases of the University Clinical Hospital (SKB) Mostar. The aim of this study is to assess the frequency and reasons for performing karyotyping in neonatology practice over the past 15 years in the Herzegovina region.

Material and methods A retrospective epidemiological study was conducted covering a 15-year period from January 1, 2009, to December 31, 2023. The study included 150 newborns who underwent karyotype testing at the Intensive Care and Neonatology Department of the Clinic for Children's Diseases at University Clinical Hospital (SKB) Mostar.

Results Over the 15-year period, 48% (73/150) of the karyotypes were classified as normal, while 51% (77/150) were identified as pathological. The most common chromosomal abnormality was trisomy 21, which accounted for 70.13% (54/77) of the pathological cases. The results indicated that a majority of the fathers were older than 35 years (62.33%, or 48/77), whereas the age of the mothers was not statistically significant in this study. Additionally, 57% of multiparous women gave birth to children with chromosomal abnormalities. Premature newborns were more likely to have positive karyotype results.

Conclusion This research found no significant difference in the occurrence rates of pathological versus physiological karyotypes. Just over 50% of the children had confirmed karyotype deviations from normal variations. However, this suggests that healthcare resources may be misallocated in performing karyotyping, as the significance of the results may not always justify the testing.

Keywords

Karyotype / Neonatology practice / Trisomy 21

Cite this article

Download citation ▾
Svjetlana Grubeša Raguž, Marjana Jerković Raguž, Marija Novaković Bošnjak, Darinka Šumanović-Glamuzina, Tomica Božić. Karyogram in neonatology: Necessity or past?. Global Medical Genetics, 2025, 12(03): 100053 DOI:10.1016/j.gmg.2025.100053

登录浏览全文

4963

注册一个新账户 忘记密码

Ethical approval and consent to participate

This retrospective study was conducted according to all the ethical principles of the University Clinical Hospital Mostar. Ethical Approval was obtained from the Ethics Committee of the Clinical Hospital Center Mostar (reference number 1384/23, dated 06/07/2023).

Funding

This study was funded by the authors, who bore the costs of research the article.

Declaration of Competing Interest

The authors report no conflicts of interest. The authors alone are responsible for the content and composition of the paper.

Acknowledgment

We would like to express our gratitude to all those who helped us during the writing of this manuscript. Thanks to all the peer reviewers for their opinions and suggestions.

Author contributions

Svjetlana Grubeša Raguž and all authors designed the research study. All authors read and approved the final manuscript.

References

[1]

J. McGowan-Jordan, A. Simons, M. Schmid, (eds), ISCN, 1st ed., Karger Publishers, p139, 2016.

[2]

R.P. Verma, Evaluation and risk assessment of congenital anomalies in neonates, Children 8 (10) (2021 Sep 28)862, https://doi.org/10.3390/children8100862.

[3]

P.D. Turnpenny, S. Ellard, Chromosomes and Cell Division, In: Emery’s Elements of Medical Genetics, Fifteenth Ed., Elsevier, 2017, pp. 24-42.

[4]

Touraine R. Orphanet: Down syndrome [Internet]. Available from: https://www.orpha.net/ 2019 [cited 2020 May 8].

[5]

P. Kumar, B.K. Burton, Congenital Malformations:Evidence-Based Evaluation and Menagment, Mc-Graw-Hill Professional, New York, 2008.

[6]

A.M. D`Gamma, P.B. Agrawal, Genomic medicine in neonatal care: progress and challenges, Eur. J. Hum. Genet. 31 (12) (2023 Dec) 1357-1363, https://doi.org/10.1038/s41431-023-01464-z.

[7]

J. Carroll, K. Wigby, S. Murray, Genetic testing strategies in the newborn, J. Perinatol. 40 (7) (2020 Jul)1007-1016, https://doi.org/10.1038/s41372-020-0697-y.

[8]

L. Pasquier, M. Fradin, E. Cherot, et al. Karyotype is not dead yet!, Eur. J. Med. Genet. 59 (1) (2016 Jan)11-15, https://doi.org/10.1016/j.ejmg.2015.11.016.

[9]

A. Blanco-Montano, M. Ramos-Arenas, B.A. Yerena-Echevarria, et al., Factores de riego en el origen del sindrome de down (Risk factors in the origin of down syndrome), Rev. Med. Inst. Mex. Seguro Soc. 61 (5) (2023 Sep 4)638-644, https://doi.org/10.5281/zenodo.8316459.

[10]

E.G. Allen, S.B. Freeman, C. Druschel, et al., Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects, Hum. Genet. 125 (1) (2009 Feb)41-52, https://doi.org/10.1007/s00439-008-0603-8.

[11]

A. Kurtović-Kozarić, L. Mehinović, R. Malešević, et al., Ten-year trends in prevalence of down syndrome in a developing country: impact of the maternal age and prenatal screening, Eur. J. Obstet. Gynecol. Reprod. Biol. (2016), https://doi.org/10.1016/j.ejogrb.2016.08.038.

[12]

M. Sotonica, S. Ibrulj, S. Hasić, et al., Association of parental age and the type of down syndrome on the territory of Bosnia and Herzegoina, Med. Arc. 70 (2) (2016), https://doi.org/10.5455/medarh.2016.70.88-91.

[13]

M. Mikwar, A.J. MacFarlane, F. Marchetti, Mechanisms of oocyte aneuploidy associated with advanced maternal age, Mutat. Res. Rev. Mutat. Res. 785 (2020 Jul- Sep) 108320, https://doi.org/10.1016/j.mrrev.2020.108320.

[14]

D. Šumanović-Glamuzina, T. Soldo, M. Jerković Raguž, Down sindrom u regiji zapadne Hercegovine u petogodišnjem razdoblju-dinamika incidencije, Zdr. Glas. 8 (1) (2022) 137-143.

[15]

P. Trevisan, R.F. Rosa, D.B. Koshiyama, et al., Congenital heart disease and chromossomopathies detected by the karyotype, Rev. Paul. Pedia. 32 (2) (2014 Jun)262-271, https://doi.org/10.1590/0103-0582201432213213.

[16]

P. Trevisan, T.D. Zen, R.F. Rosa, et al., Chromosomal abnormalities in patients with congenital heart disease, Arq. Bras. Cardiol. 101 (6) (2013 Dec)495-501, https://doi.org/10.5935/abc.20130204.

[17]

B. Chu, Z. Liu, Y. Liu, et al., The role of advanced parental age in reproductive genetics, Reprod. Sci. 30 (10) (2023 Oct)2907-2919, https://doi.org/10.1007/s43032-023-01256-2.

[18]

A. Keltsas, E. Moustakli, A. Zikopoulos, et al., Impact of advanced parental age on fertility and risks of genetic disorders in offspring, 14, Genes 14 (2) (2023 Feb) 486, https://doi.org/10.3390/genes14020486.

[19]

R. Gorazd, B. Peterlin, DNA testiranje u medicini, Medicina 45 (1) (2009) 38-43.

PDF (855KB)

25

Accesses

0

Citation

Detail

Sections
Recommended

/